Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.
A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...
Ir-Vax is under clinical development by ImmunoRestoration and currently in Phase I for Triple-Negative Breast Cancer (TNBC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback